insights_auto
Outlook: 80.7% bullish·0.0% bearish
Go to analysischevron_right
VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$504.73
arrow_downward
-0.40%(-2.01) 1D
$504.73
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$509.50
High
$509.50
Low
$499.95
Mkt. cap
127.93B
Avg. vol.
999.46K
Volume
936.56K
P/E ratio
29.37
52-wk high
$560.25
52-wk low
$400.74
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
Open
$509.50
High
$509.50
Low
$499.95
Mkt. cap
127.93B
Avg. vol.
999.46K
Volume
936.56K
P/E ratio
29.37
52-wk high
$560.25
52-wk low
$400.74
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
Yahoo Finance UK
·
22 hours ago
Vertex Pharmaceuticals And 2 Other Top Gene Therapy Stocks
Zacks
·
22 hours ago
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Yahoo Finance
·
23 hours ago
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
The Motley Fool
·
1 day ago
Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com